Uncategorized

 Media Contact: 

Heath Meyer 

heath@teamseismic.com 

858-768-1527 

Activ Surgical Appoints Paul Meister to Board of Directors

Former Chairman of the Board of Thermo Fisher Scientific joins Board of Directors at surgical intelligence startup focused on democratizing surgical care

BOSTON, MA — July 8, 2020 — Activ Surgical, a digital surgery pioneer, today announced that healthcare executive Paul Meister has been named to the company’s Board of Directors. Meister, who served in senior executive and board roles for publicly traded companies and innovative start-ups, including Chairman of the Board of Thermo Fisher Scientific, brings substantial expertise in guiding high-growth companies to commercial success.

“Paul is widely regarded as a proven executive and trusted advisor in the healthcare industry,” said Todd Usen, Chief Executive Officer, Activ Surgical. “His direction and counsel will be invaluable to the team at Activ Surgical as we bring our surgical intelligence and sensing platform to market to reduce preventable surgical errors and to deliver significant overall savings to healthcare systems.”

With this appointment Meister joins current board members Emily Casey of DNS Capital, Ashok Krishnamurthi of GreatPoint Ventures, Activ Surgical CEO Todd Usen and Activ Surgical Co-Founder and Chief Science Officer Dr. Peter Kim. 

“Activ Surgical’s collaborative approach to surgery – uniquely combining robotics precision and human judgment – has the potential to transform surgical outcomes for the better,” said Meister. 

“The opportunity to advise Activ Surgical and work with the Board to accelerate the availability of new technology that democratizes surgical care and improves patient outcomes is a powerful value proposition. I look forward to bringing my experiences and insight to accelerate the company’s success.”

Mr. Meister brings over three decades of experience to Activ Surgical’s board, serving in senior executive and board roles for high-growth and publicly traded companies. Mr. Meister is co-founder, and since 2008, Chief Executive Officer of Liberty Lane Partners, LLC, a private investment company with investments in healthcare, technology and distribution-related industries and co-founder and Vice Chairman of Perspecta Trust, a trust company that provides trust and investment services. Mr. Meister is also Chairman of Arbor Biotechnologies and Amneal Pharmaceuticals. Previously, he served as President of MacAndrews & Forbes Incorporated (“M&F”), a private company that owns or controls a diverse set of companies, including Revlon, Scientific Games, Harlan Clarke Holdings Corp., vTv Therapeutics LLC, SIGA Technologies, and AM General. Prior to that role, he was Chairman and CEO of inVentiv Health (now Syneos Health), a leading provider of commercial, consulting and clinical research services to the pharmaceutical and biotech industries. Mr. Meister was Chairman of Thermo Fisher Scientific, Inc., a scientific instruments equipment and supplies company. He was previously Vice Chairman of Fisher Scientific International, Inc., a predecessor of Thermo Fisher Scientific, Inc., and Chief Financial Officer of Fisher Scientific International, Inc. 

Mr. Meister presently serves on the board of Aptiv PLC, Quanterix, Oaktree Acquisition Corporation and Truvian Sciences, as well as several venture-stage private companies. In addition, he is Co-Chair of the University of Michigan’s Life Sciences Institute External Advisory Board and is Chair of the Provost’s Advisory Committee. He also serves on the Board of New York Stem Cell Foundation. Mr. Meister holds a B.A. from the University of Michigan and a M.B.A from Northwestern University’s Kellogg School of Management.

For more information on the Activ Surgical Board of Directors team, please visit https://www.activsurgical.com/#about.

About Activ Surgical 

Activ Surgical, the company that completed the world’s first autonomous robotic surgery of soft tissue, is building hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons. Activ Surgical’s patent-protected surgical software platform reduces unintended and preventable surgical complications by enhancing a surgeon’s intra-operative decision making. Activ Surgical is privately held, and backed by DNS Capital, GreatPoint Ventures (GPV), Tao Capital Partners, SONY Innovation Fund, Rising Tide Financial, WS Investment Company and Mintz. More information can be found at www.activsurgical.com.

BOSTON, May 21, 2020 /PRNewswire/ — Activ Surgical, a pioneering digital surgery company focused on improving surgical efficiency, accuracy, patients outcomes and accessibility, today announced the appointment of Subhrangshu (Sub) Datta as Chief Operating Officer (COO). Sub will be responsible for overseeing business operations as the company commercializes its offering in the U.S. market later this year, and scales the offering to support global expansion plans in 2021.

“Sub is a proven leader with an exceptional blend of operating and technical expertise in the digital health and medical device categories,” said Todd Usen, CEO, Activ Surgical. “His passion for using technology to transform healthcare fully aligns with our mission to commercialize a first-of-its-kind surgical intelligence and sensing platform that revolutionizes surgery, improves patient outcomes and provides significant overall savings to healthcare systems. As our first product becomes commercially available later this year, Sub will focus on implementing scalable business processes that will enable us to scale for maximum impact.”

Sub is a successful entrepreneur and global medtech executive with more than 15 years of experience delivering transformational growth in medical devices and digital health. Prior to joining Activ Surgical, he held C-level positions at venture backed tech startups, including serving as Co-Founder and CEO of CompanionMx, Inc. and Chief Business Officer at Soft Robotics, Inc. Sub also held senior leadership roles in building and scaling start-up business units in Women’s Health as Head of U.S. Sales and Global Marketing at Smith & Nephew, which was eventually sold to Medtronic for $350M, and as Head of U.S. Fertility Technologies at EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany. He also served as the General Manager in orthopedic trauma for the emerging markets for Adler Medequip, Smith & Nephew’s wholly owned subsidiary, leading the company to double digit year-over-year growth.

Sub has an MBA from MIT Sloan School of Management as a Leaders for Global Operations Fellow, MS in Engineering Systems from MIT, MS in Materials Science & Engineering from Ohio State University and Bachelors of Engineering degree in Metallurgical Engineering from IIT, Roorkee. He holds three issued and two pending patents, and has been awarded multiple innovation awards throughout his career.

“The opportunity to play a prominent role in positively impacting the future of surgery with preeminent experts in robotics and surgical imaging served as primary motivators to join the Activ Surgical leadership team,” said Datta. “I am deeply committed to Activ Surgical’s mission to empower global access to best-in-class surgery, regardless of location, with the potential to save millions of lives in the process. I look forward to partnering with Todd and the senior leadership team to bring Activ Surgical’s surgical intelligence and sensing platform to market and in the hands of surgeons who can use our products to make better informed decisions and improve patient outcomes.”

For more information on the Activ Surgical executive team, please visit https://www.activsurgical.com/#about.

About Activ Surgical

Founded in 2017, Activ Surgical is a first-of-its-kind digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility for both endoscopic and robotically-assisted procedures. The company completed the world’s first autonomous robotic surgery of soft tissue, and is building hardware-agnostic surgical software that allows minimally invasive surgical systems to autonomously collaborate with surgeons. Activ Surgical’s patent-protected surgical software platform reduces unintended and preventable surgical complications by using artificial intelligence, computer vision, machine learning and analytics to enhance a surgeon’s intra-operative decision making. Activ Surgical is privately held, and backed by leading global venture capital firms including DNS Capital, GreatPoint Ventures (GPV), Tao Capital Partners, SONY Innovation Fund, Rising Tide Financial, WS Investment Company and Mintz. More information can be found at www.activsurgical.com.

‍

View original content to download multimedia: